Silver Book Fact

Average Annual Direct Medical Costs Per Person with Parkinson’s Disease

Fact image

The Economic Burden of Parkinson’s Disease; 2019. Accessed June 11, 2019

Reference

Title
The Economic Burden of Parkinson’s Disease
Publication Date
2019

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • One study found that dopaminergenic therapies for Parkinson’s disease patients resulted in lower dyskinesias as well as lower incidences of freezing, drowsiness, and edema–resulting in better quality-of-life through symptom control.  
  • Based on rates of admission in 1998, delaying admission of Alzheimer’s patients to nursing homes by 1 month could save as much as $1.12 billion a year.  
  • Medicaid Costs, 5-Year Delayed Onset  
  • A study of Parkinson’s disease treatments found that pramipexole is a cost-effective treatment for early and advanced Parkinson’s disease. The total cost-effectiveness ratio was $8,837/QALY for patients with early Parkinson’s…  
  • The U.S. Food and Drug Administration has approved five drugs that temporarily improve Alzheimer’s disease symptoms.